New blood test aims to catch deadly pancreatic tumors earlier
NCT ID NCT05847855
Summary
This study is testing a new blood test that analyzes DNA fragments to try to detect pancreatic neuroendocrine tumors (pNETs) at an early stage. It will involve 1,000 participants who have been diagnosed with specific pancreatic tumors but have not yet started treatment. The goal is to see if this less invasive test can accurately find these hard-to-detect tumors early and correctly tell them apart from other pancreatic cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC NEUROENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University shanghai cancer center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact
Contact Phone: •••-•••-••••
Contact
-
West China Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.